Trial intelligence / Profile preview

Remimazolam vs propofol for anesthesia induction in elderly hip surgery

ChiCTR2300071696Phase 4Not yet recruiting

Sponsor
Sichuan Provincial Orthopedic Hospital
Start
May 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in hip fracture and hip osteoarthritis (2 arms), sponsored by Sichuan Provincial Orthopedic Hospital. Primary endpoints: Mean arterial pressure, Systolic blood pressure and 3 more. Planned start May 2023; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

hip fracturehip osteoarthritis

Beyond the preview

Go deeper on ChiCTR2300071696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300071696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call